Efficacy and safety of adding rivaroxaban to the anti-platelet regimen in patients with coronary artery disease: a systematic review and meta-analysis of randomized controlled trials

Peer Review reports

Original Submission
17 Jan 2018	Submitted	Original manuscript
13 Feb 2018	Reviewed	Reviewer Report - Corina Serban
27 Feb 2018	Reviewed	Reviewer Report - Peter Penson
21 Mar 2018	Author responded	Author comments - Jun Yuan
Resubmission - Version 2
21 Mar 2018	Submitted	Manuscript version 2
29 Mar 2018	Author responded	Author comments - Jun Yuan
Resubmission - Version 3
29 Mar 2018	Submitted	Manuscript version 3
Publishing
23 Apr 2018	Editorially accepted
2 May 2018	Article published	10.1186/s40360-018-0209-2

Back to article page